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534 Y.-H. Chang et al.conducted to collect information on sociodemographic characteristics, immunologic and viro-
logic status, sexual partners and patterns of sexual behavior, and use of recreational drugs.
Results: During the study period, 310 HIV-infected MSM with a mean age of 35.5 years were
enrolled, of which 82.3% (nZ 255) were sexually active and 37.4% (nZ 116) used recreational
drugs in the past 6 months. Syphilis was self-reported in 46.5% (n Z 144) of the participants
after HIV infection was diagnosed and 37.5% (112/299) had serologic evidence of syphilis within
1 year before enrollment. Multivariate logistic regression analysis limited to those who were
receiving cART showed that higher CD4 counts [adjusted odds ratio (AOR): 1.17; 95% confi-
dence interval (CI): 1.02e1.34], lower educational achievement (AOR: 1.95; 95% CI: 1.05
e3.63), serosorting (AOR: 3.32; 95% CI: 1.04e10.63), and use of recreational drugs (AOR:
2.55; 95% CI: 1.26e5.13) were associated with syphilis.
Conclusion: Improved immune status, lower educational achievement, serosorting, and use of
recreational drugs were associated with syphilis among HIV-infected MSM who were receiving
cART. These findings suggest that strengthening client-specific counseling is needed to reduce
risks for syphilis among HIV-infected MSM in Taiwan.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Since 1996, the widespread use of combination antiretro-
viral therapy (cART) has not only lowered morbidity and
mortality from human immunodeficiency virus (HIV)
infection,1e3 but also improved the quality of life in pa-
tients living with HIV infection and acquired immunodefi-
ciency syndrome (AIDS).4,5 However, rising rates of sexually
transmitted infections (STIs) have been observed among
patients living with HIV infection and AIDS who have access
to cART.6,7 Several STI epidemics have been well docu-
mented in the HIV populations, especially in HIV-infected
men who have sex with men (MSM).8e11 With the avail-
ability of cART, HIV-infected MSM who have achieved un-
detectable plasma HIV RNA load and favorable
immunologic reconstitution have concerns with trans-
mitting HIV to sexual contacts alleviated and are more
likely to engage in unprotected sex,12,13 which may in-
crease the risk for transmission of STIs and HIV.14,15 Those
increased high-risk sexual behaviors among HIV-infected
MSM were having unprotected sex with HIV-infected part-
ners (serosorting), with partners whose HIV serostatus are
unknown, or with casual partners.13,16e19 Furthermore, use
of recreational drugs may further lead to an increase in
high-risk sexual behaviors among MSM and HIV-infected
MSM.20e22
As of December, 31, 2012, 24,239 people living with HIV
and AIDS have been reported to the Centers for Disease
Control, Taiwan, and MSM accounting for 80% of newly
diagnosed HIV infections have re-emerged as the leading
risk group for HIV infection after control of the outbreak of
HIV infection among injection drug users between 2003 and
2007.23 A high prevalence and incidence of STIs has also
been reported among HIV-infected patients and HIV-
infected MSM in Taiwan,24e26 and more than 40% of the
HIV-infected Taiwanese patients with syphilis failed to
achieve a serologic response despite treatment.27 In the
case management program implemented among HIV-
infected patients in Taiwan, 10.4% of the MSM developed
new-onset syphilis during the 1st year of enrollment, and ahigher CD4 lymphocyte count and use of recreational drugs
were found to be associated with incident syphilis in the
MSM.26 In the anonymous voluntary counseling and testing
for HIV in northern Taiwan,28 the overall prevalence of
syphilis was 2.2%, and the incidence rate was estimated as
1.6/100 person-years. MSM, a history of STIs, and HIV
infection were statistically significantly associated with
syphilis, and use of recreational drugs and engaging in anal
sex increased the risk of syphilis. However, little is known
with respect to the role that the serostatus of sexual
partners and the relationship with sexual partners may play
in syphilis in Taiwan. This study aimed to identify factors
that were associated with syphilis among HIV-infected MSM
in Taiwan, where access to cART and related HIV care is
provided free of charge.Methods
Study population and setting
We conducted a cross-sectional survey at the National
Taiwan University Hospital, the largest hospital designated
for HIV care in Taiwan, from March 2011 to October 2011.
Eligible participants were patients who identified them-
selves as MSM, were aged 20 years or older, and did not miss
two previous clinic appointments that usually occurred
every 1e3 months for those who initiated cART and 3e6
months for those who did not initiate cART. We invited
eligible patients who were in the waiting area at the
outpatient clinics. The average number of patients in each
outpatient clinic was 35e50. It took about 15 minutes to
complete the questionnaire. HIV-infected patients have
free-of-charge access to HIV care, including testing for CD4
lymphocyte count and plasma HIV RNA load and cART, ac-
cording to the national treatment guidelines for antiretro-
viral therapy. Laboratory tests for syphilis [rapid plasma
reagin (RPR)] and viral hepatitis were recommended to be
performed at least once every year and on an as-needed
basis as dictated by the clinical presentation.
Syphilis and men who have sex with men 535Questionnaire interview
A self-administered, anonymous questionnaire interview
was conducted and a standardized case record form was
used to collect information on demographics, receipt of
cART, self-reported calendar year of HIV diagnosis, and
history of syphilis after HIV diagnosis; sexual behavior in the
past 6 months; recreational drug use in the past and in the
past 6 months; the latest RPR titer; and immunologic and
virologic data that were notified by the treating physicians
or case managers. Data on sexual behavior in the past 6
months included information on the type of sexual partners
(main and casual), HIV serostatus of sexual partners, the
frequency of consistent condom use during sexual contact,
the frequency of condom use during anal sex, oral sex, and
other sexual contacts with sexual partners, the frequency
of condom use with HIV-infected partners. All items of
condom use were measured on a 5-point Likert scale
(never, rarely, sometimes, often, and always). We evalu-
ated the baseline demographic, clinical, sexual behavior
characteristics in the past 6 months and recreational drug
use in the past and in the past 6 months to examine the
association with syphilis. The study protocol and question-
naire were reviewed and approved by the Research Ethics
Committee of the hospital (Registration No. 201103036RC).
Laboratory investigations
Tests for syphilis were performed using the RPR test (Macro-
Vue RPR Card Tests; BD, USA) and Treponema pallidum
hemagglutination assay (FTI-SERODIA-TPPA; Fujirebio Taiwan
Inc., Taoyuan, Taiwan). Patients who received a diagnosis of
early syphilis (primary, secondary, or early latent syphilis)
were encouraged to submit a voided urine specimen for
detection of Chlamydia trachomatis and Neisseria gonor-
rhoeae,whichwas performedwith theuse ofamultiplex real-
time polymerase chain reaction (PCR) assay on an automated
system (m2000; Abbott Molecular Diagnostics, Des Plaines, IL,
USA). Results were reported as positive or negative. Serol-
ogies for hepatitis B surface antigen (HBsAg), anti-HBs anti-
body, and immunoglobulin G-hepatitis B core antibody (anti-
HBc antibody) were determined using an enzyme immuno-
assay (Abbott Laboratories, Abbott Park, IL, USA). Antibodies
to hepatitis C virus (HCV) were determined using a third-
generation enzyme immunoassay (Ax SYM HCV III; Abbott
Laboratories, North Chicago, IL, USA). Plasma HIV RNA load
was quantified using the COBAS AMPLICOR HIV-1 Monitor test
(COBAS AMPLICOR version 1.5; Roche Diagnostics Corpora-
tion, Indianapolis, IN, USA) with a lower detection limit of 40
copies/mL, and CD4 countwas determined using FACFlow (BD
FACSCalibur; Becton Dickinson, San Jose, CA, USA).
Definitions
Chronic hepatitis B infection was defined as persistent
presence of HBsAg for 6 months or longer. The cART that was
introduced into Taiwan in April 1997 was defined as the
combination of at least three antiretroviral agents contain-
ing two nucleoside reverse-transcriptase inhibitors (NRTIs)
plus protease inhibitors, one non-NRTI or integrase inhibitor;
or three NRTIs. Being sexually active was defined as havingany type of sexual contacts with more than one main or ca-
sual partner(s) in the past 6months before study enrollment.
Statistical analysis
Data were analyzed to determine the statistical signifi-
cance of differences in demographic characteristics,
immunologic, and virologic status, receiving cART or not
between the participants with syphilis and those without
syphilis after HIV diagnosis was made. Categorical variables
were compared by Chi-square test, and continuous vari-
ables were compared by Student t test. In addition, we also
analyzed the behavior characteristics of the participants
from three dimensions: sexual partner(s), condom use, and
recreational drug use. Univariate analysis was performed to
assess the relationship between sexual behavior and rec-
reational drug uses and syphilis. Multivariate logistic
regression analysis was used to identify factors associated
with syphilis including variables with p < 0.05 in the uni-
variate analysis, and the effects of age, education,
receiving cART or not, CD4 count, and plasma HIV RNA load
(log10) were also forced into the multivariable model. All
statistical analyses were performed with SAS, version 9.1.2.
Results
During the 8-month study period, a total of 310 HIV-infected
MSM were enrolled and provided valid responses to the
questionnaire interview. Only about 10e20% of the patients
in each clinic session participated in this study. The de-
mographic, immunologic, and virologic characteristics of the
participants are shown in Table 1. The mean age of the
participants was 35.5 years (standard deviation: 7.3) and
most (80.0%) were receiving cART. Half of the participants
(51.0%) had CD4 count  500 cells/mL, and 64.4% (199/309)
had plasma HIV RNA load <40 copies/mL. The estimated
interval since HIV diagnosis and the interview (mean
years  standard deviation) in participants with syphilis and
without syphilis were 5.7  4.1 and 4.6  3.7 years,
respectively.
A diagnosis of syphilis had ever been made in 46.5% of
the participants after they received the diagnosis of HIV
infection and 37.5% (112/299) had RPR titers  4 within 1
year before enrollment into this survey. Chronic hepatitis B
infection was identified in 17.6% (40/277) of the partici-
pants, while the seroprevalence of HCV was 8.7% (26/300).
During the study period, the prevalence of C. trachomatis
and N. gonorrhoeae infection was 8.5% (n Z 9) and 3.8%
(n Z 4), respectively, in the 106 participants (34.2%) who
reported ever receiving a diagnosis of early syphilis and
submitted urine specimens for PCR assays.
Most participants (82.3%) were sexually active in the
preceding 6 months before enrollment; 93 participants
(30.0%) reported having both main partner(s) and casual
partner(s), 77 (24.8%) had only casual partner(s), 88 (28.4%)
had only main partner(s), and 52 (16.8%) reported not
having any partners. More than 40% (44.8%) of the partici-
pants reported that they did not know the HIV serostatus of
their main or casual partner(s), and 26.9% (n Z 83) re-
ported having some or all main or casual partner(s) who
were HIV positive (serosorting).
Table 1 Demographics and clinical characteristics of 310 HIV-infected MSM, including 248 who received cART
Total All participants (N Z 310) p Only participants receiving cART included
(N Z 248)
p
N Z 310 Syphilis (e)
(N Z 166, 53.5%)
Syphilis (þ)
(N Z 144, 46.5%)
Syphilis (e)
(N Z 125, 50.4%)
Syphilis (þ)
(N Z 123, 49.6%)
Characteristics
Age (mean  SD), years 35.45  7.29 35.79  7.64 35.06  6.87 0.38 37.34  7.59 35.24  6.82 0.02
35, N (%) 164 (52.9) 84 (51.2) 80 (48.8) 0.38 52 (44.1) 66 (55.9) 0.06
>35 146 (47.1) 82 (56.2) 64 (43.8) 73 (56.2) 57 (43.8)
Education, N (%)
Below university 121 (39.2) 57 (47.1) 64 (52.9) 0.08 49 (45.4) 59 (54.6) 0.18
University and above 188 (60.8) 108 (57.4) 80 (42.6) 75 (54.0) 64 (46.0)
CD4 count, cells/mL
(mean  SD)
(median, IQR)
529.99  225.97
(504, 369e642)
507.28  216.55 556.02  234.37 0.06 518.87  223.24 581.09  234.95 0.03
<500, N (%) 152 (49.0) 91 (59.9) 61 (40.1) 0.03 65 (58.6) 46 (41.4) 0.02
500 158 (51.0) 75 (47.5) 83 (52.5) 60 (43.8) 77 (56.2)
Plasma HIV RNA load log10 copies/mL
(mean  SD)
(median, IQR)
2.32  1.21
(1.60, 1.60e2.61)
2.38  1.23 2.25  1.18 0.34 1.76  0.41 1.87  0.74 0.13
Receipt of cART, N (%)
No 62 (20.0) 41 (66.1) 21 (33.9) 0.03 d d d
Yes 248 (80.0) 125 (50.4) 123 (49.6) d d
cART Z combination antiretroviral therapy; HIV Z human immunodeficiency virus; IQR Z interquartile range; MSM Z men who have sex with men; SD Z standard deviation.
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Table 2 Use of recreational drugs in the past 6 months and the frequency of condom use during sexual activity
Used (N Z 116) Not used (N Z 57) c2 value
n (%) n (%)
Frequency of consistent condom use 31.85*
Sometimes/rarely/never 54 (46.6) 7 (12.3)
Always/often 58 (50.0) 35 (61.4)
No sexual activity in the past 6 months 4 (3.4) 15 (26.3)
Anal sex: the frequency of condom use 30.44*
Sometimes/rarely/never 46 (39.7) 6 (10.5)
Always/often 65 (56.0) 34 (59.7)
No anal sex or sexual activity in the past 6 months 5 (4.3) 17 (29.8)
Oral sex: the frequency of condom use 20.96*
Sometimes/rarely/never 95 (81.9) 32 (56.1)
Always/often 15 (12.9) 8 (14.0)
No oral sex or sexual activity in the past 6 months 6 (5.2) 17 (29.8)
Frequency of condom use with HIV-infected sexual partner 27.84*
Sometimes/rarely/never 43 (37.1) 4 (7.6)
Always/often 27 (23.3) 12 (22.6)
Unknown serostatus of sexual partner(s) 41 (35.3) 23 (43.4)
No sexual activity in the past 6 months 5 ( 4.3) 14 (26.4)
“Used group” are those participants who ever used recreational drugs in the past as well as in the past 6 months, whereas “not used
group” are those who used recreational drugs only in the past, but not in the past 6 months.
* p < 0.0001.
HIV Z human immunodeficiency virus.
Syphilis and men who have sex with men 537The frequency of condom use varied with forms of sex-
ual contact. Of the 310 participants who responded to the
query on frequency of condom use, 27.7% (nZ 86) reported
that they sometimes/rarely/never used condom consis-
tently during sexual activity, 24.7% (76/308) and 64.7%
(200/309) participants sometimes/rarely/never used
condom during anal and oral sex, respectively, in the past 6
months. Among the participants who reported a lower
frequency of condom use during anal sex, 65.8% (50/76)
reported that they sometimes/rarely/never used condom
when having anal sex with HIV-positive main or casual
partner(s) in the past 6 months; the rate decreased to 30.3%
(23/76), when they had anal sex with partner(s) whose HIV
serostatus was unknown.
Of the 310 participants, 37.4% (116) admitted to use of
recreational drugs in the past and in the past 6 months; and
18.4% (57) reported that they used recreational drugs only
in the past, but not in the past 6 months; and 44.2% (137)
reported that they never used recreational drugs. Partici-
pants who used recreational drugs in the past 6 months were
less likely to use a condom during oral sex (95/116) and
practice serosorting (43/116). There was a statistically sig-
nificant association between recreational drug use and the
frequency of condom use during all types of sexual contacts
(Table 2). Among the 116 participants who reported using
recreational drugs in the past and in the past 6 months,
60.3% (n Z 70) and 55.2% (n Z 64) used 3,4-
methylenedioxy-N-methylamphetamine (ecstasy) and keta-
mine, 48.3% (n Z 56) used amyl nitrites (poppers, RUSH),
and 51.7% (n Z 60) used sildenafil citrate (Viagra). Up to
44.8% had used a variety of drugs within the past 6 months,
including ecstasy, ketamine, poppers, and sildenafil citrate.
The participants with syphilis had higher CD4 counts
than those without syphilis (556.0 vs. 507.3 cells/mL). Whenthe analysis was limited to participants who were receiving
cART, the participants with syphilis were younger and had
higher CD4 counts than those without syphilis (Table 1). In
univariate analyses (Table 3), the factors identified to be
associated with syphilis included having some (or all) main
or casual sexual partner(s) who were also seropositive for
HIV; never, rarely, or sometimes used a condom consis-
tently during sexual activity; condom use while having anal
sex and oral sex; and use of recreational drugs in the past
and in the past 6 months. In the final multivariable model,
receipt of cART [adjusted odds ratio (AOR): 7.02; 95%
confidence interval (CI): 2.06e23.92], higher CD4 counts
(AOR: 1.13; 95% CI: 1.00e1.27), plasma HIV RNA load (AOR:
1.51; 95% CI: 1.00e2.27), and use of recreational drugs in
the past as well as in the past 6 months (AOR: 2.04; 95% CI:
1.10e3.79) were associated with syphilis (Table 4).
Because most participants (80%) were receiving cART at
enrollment, we repeated multivariate logistic regression
analysis by limiting the analyses to those participants who
were on cART. The results indicated that educational
achievement below university level (AOR: 1.95; 95% CI:
1.05e3.63), higher CD4 counts (AOR: 1.17; 95% CI:
1.02e1.34), some (or all) main or casual partner(s) being
HIV positive (AOR: 3.32; 95% CI: 1.04e10.63), and use of
recreational drugs in the past and in the past 6 months
(AOR: 2.55; 95% CI: 1.26e5.13) were significantly associ-
ated with syphilis (Table 4).Discussion
In this survey conducted among the participants with access
to cARTwho were sexually active MSM, we found that a high
proportion of participants had syphilis after they received
Table 3 Results of univariate analysis to identify associated factors with syphilis
Variable All participants Only participants receiving cART
All
(N Z 310)
Syphilis (e)
(N Z 166)
Syphilis (þ)
(N Z 144)
OR (95% CI) p All
(N Z 248)
Syphilis (e)
(N Z 125)
Syphilis (þ)
(N Z 123)
OR (95% CI) p
Had main or casual partner(s) in the past 6 months
Had both main and casual partners 93 (30.0) 45 (48.4) 48 (51.6) 2.02 (0.99, 4.06) 0.0503 75 (30.2) 34 (45.3) 41 (54.7) 2.49 (1.16, 5.36) 0.019
Only had casual partner(s) 77 (24.8) 38 (49.4) 39 (50.6) 1.94 (0.94, 4.00) 0.0736 56 (22.6) 22 (39.3) 34 (60.7) 3.19 (1.41, 7.23) 0.005
Only had main partner(s) 88 (28.4) 49 (55.7) 39 (44.3) 1.50 (0.74, 3.06) 0.2600 71 (28.6) 38 (53.5) 33 (46.5) 1.79 (0.83, 3.89) 0.138
Did not have any partner 52 (16.8) 34 (65.4) 18 (34.6) Ref 46 (18.6) 31 (67.4) 15 (32.6) Ref
HIV status of main or casual sexual partner(s)a
All or some being HIV-infected 83 (26.9) 32 (38.6) 51 (61.4) 3.01 (1.46, 6.20) 0.0028 66 (26.8) 20 (30.3) 46 (69.7) 4.75 (2.12, 10.68) 0.0002
Unknown 138 (44.8) 73 (52.9) 65 (47.1) 1.68 (0.87, 3.26) 0.1237 105 (42.7) 53 (50.5) 52 (49.5) 2.03 (0.98, 4.19) 0.06
All being HIV-uninfected 35 (11.4) 26 (74.3) 9 (25.7) 0.65 (0.25, 1.69) 0.3803 29 (11.8) 20 (69.0) 9 (31.0) 0.93 (0.34, 2.53) 0.89
No partners in the past 6 months 52 (16.9) 34 (65.4) 18 (34.6) Ref 46 (18.7) 31 (67.4) 15 (32.6) Ref
Frequency of consistent condom use
Sometimes/rarely/never 86 (27.7) 36 (41.9) 50 (58.1) 3.10 (1.52, 6.34) 0.0019 65 (26.2) 22 (33.8) 43 (66.2) 3.91 (1.77, 8.61) 0.0007
Always/often 169 (54.5) 92 (54.4) 77 (45.6) 1.87 (0.98, 3.57) 0.0579 135 (54.4) 71 (52.6) 64 (47.4) 1.80 (0.91, 3.59) 0.09
No sexual activity in the past
6 months
55 (17.7) 38 (69.1) 17 (30.9) Ref 48 (19.4) 32 (66.7) 16 (33.3) Ref
Anal sex: frequency of condom usea
Sometimes/rarely/never 76 (24.7) 34 (44.7) 42 (55.3) 2.59 (1.30, 5.15) 0.0068 60 (24.3) 24 (40.0) 36 (60.0) 3.08 (1.44, 6.62) 0.004
Always/often 167 (54.2) 88 (52.7) 79 (47.3) 1.88 (1.03, 3.43) 0.0398 132 (53.4) 64 (48.5) 68 (51.5) 2.18 (1.13, 4.22) 0.02
No anal sex or sexual activity 65 (21.1) 44 (67.7) 21 (32.3) Ref 55 (22.3) 37 (67.3) 18 (32.7) Ref
Oral sex: frequency of condom usea
Sometimes/rarely/never 200 (64.7) 96 (48.0) 104 (52.0) 2.17 (1.20, 3.92) 0.0106 155 (62.7) 66 (42.6) 89 (57.4) 2.48 (1.31, 4.72) 0.006
Always/often 46 (14.9) 28 (60.9) 18 (39.1) 1.29 (0.58, 2.83) 0.5334 38 (15.4) 24 (63.2) 14 (36.8) 1.08 (0.45, 2.55) 0.871
No oral sex or sexual activity 63 (20.4) 42 (66.7) 21 (33.3) Ref 54 (21.9) 35 (64.8) 19 (35.2) Ref
Recreational drug uses
In the past and in the past
6 months
116 (37.4) 49 (42.2) 67 (57.8) 2.46 (1.48, 4.08) 0.0005 83 (33.5) 28 (33.7) 55 (66.3) 3.51 (1.07, 4.17) <.0001
In the past but not in the past
6 months
57 (18.4) 29 (50.9) 28 (49.1) 1.73 (0.93, 3.24) 0.0848 48 (19.3) 22 (45.8) 26 (54.2) 2.11 (1.07, 4.17) 0.03
Never used before 137 (44.2) 88 (64.2) 49 (35.8) Ref 117 (47.2) 75 (64.1) 42 (35.9) Ref
a Missing data: several participants did not answer the indicated questions.
95% CI Z 95% confidence interval; cART Z combination antiretroviral therapy; HIV Z human immunodeficiency virus; OR Z odds ratio.
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Syphilis and men who have sex with men 539the diagnosis of HIV infection. In the participants who were
receiving cART, higher CD4 counts, lower educational
achievement, serosorting, and use of recreational drugs
were statistically significantly associated with syphilis.
In this study, we found that having some (or all) HIV-
infected partner(s) in the past 6 months, either main or
casual partner(s), were associated with syphilis. This
finding is consistent with those of previous studies, which
demonstrated that HIV-infected MSM engaging in unsafe sex
with HIV-infected (serosorting) or serostatus unknown
partners(s), either main or casual partner(s), might place
themselves at risk for other STIs as well as HIV-uninfected
persons at risk for HIV.18,21 Serosorting is considered a
harm-reduction approach to reduce the risk of HIV trans-
mission among HIV-infected MSM.18 However, serosorting
may facilitate the spread of STIs when sexual partners of
the same serostatus have STIs and safe sex using condoms is
not practiced consistently. Although most STIs are treat-
able, concerns may arise with respect to the transmission
of antiretroviral-resistant HIV or HIV superinfection among
HIV-infected and noninfected people.29,30 Other STIs, such
as HCV, may also raise concerns in Taiwan because recent
acquisition of syphilis was associated with HCV serocon-
version and the incidence of recent HCV infections has
increased among the HIV-infected MSM.31Table 4 Multiple logistic regression to identify the associated f
receiving cART only
Effect All pa
(n Z
OR (95
Receipt of cART 7.02 (
Age 1.43 (
Education (low level vs. high level) 1.61 (
CD4 count (per 100-cell/mL increment) 1.13 (
Plasma HIV RNA load (log10 copies/mL) 1.51 (
HIV serostatus of main or casual sexual partner(s)
All or some being HIV-infected 1.82 (
Unknown 1.07 (
All being HIV-uninfected 0.47 (
No main or casual partners in the past 6 months Ref
Frequency of consistent condom uses
Sometimes/rarely/never 2.17 (
Always/often 1.50 (
No sexual activity in the past 6 months Ref
Anal sex: frequency of condom use
Sometimes/rarely/never 1.02 (
Always/often 1.22 (
No anal sex or sexual activity in the past 6 months Ref
Oral sex: frequency of condom uses
Sometimes/rarely/never 0.99 (
Always/often 0.72 (
No oral sex or sexual activity in the past 6 months Ref
Recreational drug uses
In the past and in the past 6 months 2.04 (
In the past but not in the past 6 months 1.72 (
Never used before Ref
95% CIZ 95% confidence interval; cARTZ combination antiretroviralUse of recreational drugs may increase risk of losing
control over safe sex practices during the sexual encoun-
ters. In this study, recreational drug use in the past and in
the past 6 months was associated with syphilis in the final
multivariate analysis. Previous studies have demonstrated
that substance uses were associated with STIs and unpro-
tected anal sex.11,16,21 Among the clients who sought
voluntary counseling and testing and subsequent follow-up
for HIV infection in Taiwan, recreational drug use and un-
protected anal sex were risk factors for HIV infection and
syphilis.28 Higher CD4 counts and recreational drug use
were also found to be associated with incident syphilis
among the HIV-infected MSM who were enrolled in the case
management program.26 It is likely that HIV-infected pa-
tients with improved health status with cART have more
opportunities to engage in sexual activities, and people
who use recreational drugs for sexual activities have more
chances to have relapses of unsafe sex.26
Previous studies have shown that unprotected sexual
behavior was significantly higher among MSM or HIV-
infected MSM who believed that cART reduces the risk of
HIV transmission or who were less concerned about HIV due
to the availability of cART and advances of HIV treatment.
In our study, we also demonstrated that higher CD4 counts
were associated with syphilis among HIV-infected MSM whoactors with syphilis in all participants and in those who were
rticipants
310)
p Only participants
receiving cART were
included (n Z 248)
p
% CI) OR (95% CI)
2.06, 23.92) 0.002 d d
0.84, 2.42) 0.18 1.54 (0.84, 2.84) 0.17
0.94, 2.78) 0.08 1.95 (1.05, 3.63) 0.03
1.00, 1.27) 0.047 1.17 (1.02, 1.34) 0.02
1.00, 2.27) 0.049 1.65 (0.97, 2.78) 0.06
0.65, 5.09) 0.25 3.32 (1.04, 10.63) 0.04
0.41, 2.81) 0.89 1.44 (0.48, 4.33) 0.52
0.14, 1.58) 0.22 0.74 (0.20, 2.79) 0.66
Ref
0.58, 8.17) 0.25 1.66 (0.38, 7.20) 0.50
0.41, 5.50) 0.54 0.92 (0.22, 3.87) 0.91
Ref
0.28, 3.64) 0.98 1.19 (0.28, 5.08) 0.82
0.37, 4.04) 0.74 1.72 (0.44, 6.67) 0.44
Ref
0.33, 3.02) 0.99 0.90 (0.27, 3.06) 0.87
0.20, 2.54) 0.61 0.50 (0.12, 2.05) 0.34
Ref
1.10, 3.79) 0.02 2.55 (1.26, 5.13) 0.009
0.87, 3.41) 0.12 2.11 (0.99, 4.51) 0.05
Ref
therapy; HIVZ human immunodeficiency virus; ORZ odds ratio.
540 Y.-H. Chang et al.were receiving cART. It is likely that quality of life for in-
dividuals with HIV has improved substantially with cART,
which may lead to resumption of sexual activity after
achieving stable immune status.
The results of this study are consistent with those of a
previous study in France that lower educational attainment
was a risk factor for syphilis acquisition among MSM.15 In
Taiwan, MSM and lower educational achievement were
associated with increased risk for amebiasis among persons
seeking voluntary counseling and testing for HIV infec-
tion.32 An association has been demonstrated between
treatment optimism-related risk behavior and lower
educational attainment among MSM.33 Another study in
Japan also found that a lower educational achievement was
associated with substance uses.34 Because of treatment
optimism, concerns with safe sex may be alleviated, and
people who had lower educational attainment might
misunderstand about HIV transmission risk while they were
taking cART. Therefore, client-specific counseling is needed
to help these patients easily learn the risk-reduction skill.
There are several limitations of this study. First, the par-
ticipants in this study were MSM who sought medical care
regularly, and our findings may not be generalizable to other
risk groups or to the patients who did not adhere to clinical
care. Second, we used self-administered questionnaire
interview toobtain information on sexual behaviors anduse of
recreational drugs in the past or within the past 6 months.
Recall bias, underreporting, or giving a falsified response to
meet social expectation may have occurred. Third, the cross-
sectional study design precludes us from assessing the sexual
relationships that are likely bedynamic amongMSM inTaiwan.
In conclusion, factors that were associated with syphilis
among HIV-infected MSM who were receiving cART in
Taiwan included lower educational achievement, higher
CD4 counts, serosorting, and use of recreational drugs. Our
study suggests that more intensive health education and
client-specific risk-reduction counseling that target HIV-
infected MSM who receive cART are needed in Taiwan.
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